D
Journey Medical Corporation DERM
$7.42 $0.020.27% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -12.94% 60.99% 170.98% -114.24% 59.81%
Total Depreciation and Amortization 29.44% 29.90% 21.60% 0.12% -23.03%
Total Amortization of Deferred Charges 93.75% 62.90% 4,600.00% 50.00% -77.06%
Total Other Non-Cash Items -50.82% 7.51% 107.50% 81.62% -59.93%
Change in Net Operating Assets 116.51% -147.03% 90.67% -313.38% -170.67%
Cash from Operations 81.80% 43.57% 113.47% -106.17% -230.41%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -66.33% -- --
Total Debt Repaid -- -- -- 94.32% --
Issuance of Common Stock 432.26% 157.91% 36.03% 1,631.82% 933.33%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 86.84% -- --
Cash from Financing -96.72% 119.73% -44.72% 97.32% 138.44%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -435.86% 122.62% -180.15% -118.68% 98.41%